Back to search

Article

Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma Pathophysiology

2024-09-20

Abstract excerpt

Gliomas are primary brain tumors that develop from glial cells within the central nervous system and are among the deadliest human cancers. Glioblastoma (GBM) is the most malignant form of glioma. NLRX1 is an innate immune pattern recognition receptor that exhibits tumor-suppressive and tumor-promoting effects that may be cancer or cell-type, context-dependent, aided by differences in the microenvironment. Here, w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dbd43f09-3725-5c6e-9b28-2aebe8a68470
DOI
10.1101/2024.09.19.613932
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma PathophysiologyDOI 10.1101/2024.09.19.613932
Select a neighboring publication to make it the new centre.